1-3 of 3
Nicholas F.S. Watson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

NKG2D Ligand Expression in Human Colorectal Cancer Reveals Associations with Prognosis and Evidence for Immunoediting

Roger W. McGilvray, Robert A. Eagle, Nicholas F.S. Watson, Ahmad Al-Attar, Graham Ball, Insiya Jafferji, John Trowsdale, Lindy G. Durrant
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (22): 6993–7002.
https://doi.org/10.1158/1078-0432.CCR-09-0991
Published: 11 November 2009
View article titled, NKG2D Ligand Expression in Human Colorectal Cancer Reveals Associations with Prognosis and Evidence for Immunoediting
Open the PDF for NKG2D Ligand Expression in Human Colorectal Cancer Reveals Associations with Prognosis and Evidence for Immunoediting in another window
Journal Articles

Overexpression of FLIPL Is an Independent Marker of Poor Prognosis in Colorectal Cancer Patients

Gustave J. Ullenhag, Abhik Mukherjee, Nicholas F.S. Watson, Ahmad H. Al-Attar, John H. Scholefield, Lindy G. Durrant
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (17): 5070–5075.
https://doi.org/10.1158/1078-0432.CCR-06-2547
Published: 04 September 2007
View article titled, Overexpression of FLIP<sub>L</sub> Is an Independent Marker of Poor Prognosis in Colorectal Cancer Patients
Open the PDF for Overexpression of FLIP<sub>L</sub> Is an Independent Marker of Poor Prognosis in Colorectal Cancer Patients in another window
Journal Articles

A Neoadjuvant/Adjuvant Randomized Trial of Colorectal Cancer Patients Vaccinated with an Anti-Idiotypic Antibody, 105AD7, Mimicking CD55

Gustav J. Ullenhag, Ian Spendlove, Nicholas F.S. Watson, Adrian A. Indar, Mukul Dube, Richard A. Robins, Charles Maxwell-Armstrong, John H. Scholefield, Lindy G. Durrant
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (24): 7389–7396.
https://doi.org/10.1158/1078-0432.CCR-06-1003
Published: 22 December 2006
View article titled, A Neoadjuvant/Adjuvant Randomized Trial of Colorectal Cancer Patients Vaccinated with an Anti-Idiotypic Antibody, 105AD7, Mimicking CD55
Open the PDF for A Neoadjuvant/Adjuvant Randomized Trial of Colorectal Cancer Patients Vaccinated with an Anti-Idiotypic Antibody, 105AD7, Mimicking CD55 in another window